1-4 of 4
Kan Yonemori
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dose Escalation Data from the Phase 1 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Japanese Patients with Advanced Solid Tumors

Jun Sato, Toshio Shimizu, Takafumi Koyama, Satoru Iwasa, Akihiko Shimomura, Shunsuke Kondo, Shigehisa Kitano, Kan Yonemori, Yutaka Fujiwara, Kenji Tamura, Takuya Suzuki, Takao Takase, Reiko Nagai, Kohei Yamaguchi, Taro Semba, Zi-Ming Zhao, Min Ren, Noboru Yamamoto
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (9): 1783–1791.
DOI: https://doi.org/10.1158/1078-0432.CCR-21-3518
Published: 02 May 2022
View article
PDF
Includes: Supplementary data
Journal Articles

Visualization of Intratumor Pharmacokinetics of [fam-] Trastuzumab Deruxtecan (DS-8201a) in HER2 Heterogeneous Model Using Phosphor-integrated Dots Imaging Analysis

Mikiko Suzuki, Shigehiro Yagishita, Kiyoshi Sugihara, Yusuke Ogitani, Tadaaki Nishikawa, Mayu Ohuchi, Takashi Teishikata, Takahiro Jikoh, Yasushi Yatabe, Kan Yonemori, Kenji Tamura, Kosei Hasegawa, Akinobu Hamada
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (14): 3970–3979.
DOI: https://doi.org/10.1158/1078-0432.CCR-21-0397
Published: 15 July 2021
View article
PDF
Includes: Supplementary data
Journal Articles

First-in-Human Phase 1 Study of MORAb-202, an Antibody–Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α–Positive Advanced Solid Tumors

Toshio Shimizu, Yutaka Fujiwara, Kan Yonemori, Takafumi Koyama, Jun Sato, Kenji Tamura, Akihiko Shimomura, Hiroki Ikezawa, Maiko Nomoto, Keiji Furuuchi, Ryo Nakajima, Takuma Miura, Noboru Yamamoto
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (14): 3905–3915.
DOI: https://doi.org/10.1158/1078-0432.CCR-20-4740
Published: 15 July 2021
View article
PDF
Includes: Supplementary data
Journal Articles

Severe Drug Toxicity Associated with a Single-Nucleotide Polymorphism of the Cytidine Deaminase Gene in a Japanese Cancer Patient Treated with Gemcitabine plus Cisplatin

Kan Yonemori, Hideki Ueno, Takuji Okusaka, Noboru Yamamoto, Masafumi Ikeda, Nagahiro Saijo, Teruhiko Yoshida, Hiroshi Ishii, Junji Furuse, Emiko Sugiyama, Su-Ryang Kim, Ruri Kikura-Hanajiri, Ryuichi Hasegawa, Yoshiro Saito, Shogo Ozawa, Nahoko Kaniwa, Jun-ichi Sawada
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (7): 2620–2624.
DOI: https://doi.org/10.1158/1078-0432.CCR-04-1497
Published: 06 April 2005
View article
PDF